Ilaprazole sodium crystal form and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- LIVZON PHARM GRP INC
- Publication Date
- 2012-10-24
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicine and relates to a new crystal form of ilaprazole sodium and a preparation method thereof. Background technique
[0002] Ilaprazole belongs to benzimidazoles and is an irreversible proton pump inhibitor. After oral administration, ilaprazole selectively enters gastric parietal cells and is converted into the active metabolite of sulfenamide, which interacts with H + , K + -Sulfhydryl action on ATPase, forming covalent binding of disulfide bonds, irreversibly inhibiting H + , K + -ATPase, produces the effect of inhibiting gastric acid secretion.
[0003] First-generation PPIs have limited clinical application because they can cause delayed gastric emptying, parietal cell swelling, and a significant rebound in gastric acid secretion after drug withdrawal. As one of the new generation of proton pump inhibitors (PPI), ilaprazole has overcome some of the defects of the original similar products to varying de...